Subscribe
Share
Share
Embed
FDA grants accelerated approval for Jazz Pharmaceuticals' Modeyso, Biogen's Alzheimer's treatment awaits subcutaneous formulation decision, and RemeGen advances cancer therapy trials.
Pharmaceutical and biotech news in 5 minutes. Drug approvals, clinical trials, and healthcare innovation.